Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

NCT00693719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Etoposide
DRUG: Irinotecan hydrochloride

Sponsor

University of Arizona

Collaborators

[object Object]